Company Filing History:
Years Active: 2019
Title: Henry Hoppe: Innovator in Insulin Delivery Methods
Introduction
Henry Hoppe is a notable inventor based in Moultonborough, NH (US). He has made significant contributions to the field of pharmaceutical delivery systems, particularly in the administration of insulin to the brain. His innovative approach aims to enhance the effectiveness of insulin treatment for patients.
Latest Patents
Henry Hoppe holds a patent for "Compositions and methods for administering insulin or insulin-like protein to the brain." This invention provides a method of intranasal delivery of a pharmaceutical composition, which includes a polysaccharide derivative of insulin protein and one or more pharmaceutically acceptable excipients. The method allows for the delivery of insulin protein to the brain through the nasal mucosa, potentially improving treatment outcomes for individuals with insulin-related conditions. He has 1 patent to his name.
Career Highlights
Henry Hoppe is associated with Xenetic Biosciences, Inc., a company focused on advancing drug delivery technologies. His work at the company has been instrumental in developing innovative solutions for pharmaceutical applications.
Collaborations
Some of his notable coworkers include Sanjay Jain and Dmitry Genkin, who contribute to the collaborative efforts at Xenetic Biosciences, Inc. Their combined expertise enhances the research and development initiatives within the company.
Conclusion
Henry Hoppe's contributions to insulin delivery methods represent a significant advancement in pharmaceutical science. His innovative patent and work at Xenetic Biosciences, Inc. highlight his commitment to improving healthcare solutions.